Your browser doesn't support javascript.
loading
Off-label use of dupilumab for the treatment of moderate to severe atopic dermatitis in children aged below 6 years of age: a case series.
Da, J; Ali, K; Lu, K; Lou, H; Qiu, Y; Shan, J; Wu, L.
Afiliação
  • Da J; Department of, Dermatology, Affiliated Hangzhou First People's Hospital, Zhejiang University School of Medicine, Hangzhou, China.
  • Ali K; Department of Dermatology, Affiliated Hangzhou First People's Hospital, Zhejiang Chinese Medical University, Hangzhou, China.
  • Lu K; Department of, Oncological Surgery, Affiliated Hangzhou First People's Hospital, Zhejiang University School of Medicine, Hangzhou, China.
  • Lou H; Department of Dermatology, Affiliated Hangzhou First People's Hospital, Zhejiang Chinese Medical University, Hangzhou, China.
  • Qiu Y; Department of Dermatology, Affiliated Hangzhou First People's Hospital, Zhejiang Chinese Medical University, Hangzhou, China.
  • Shan J; Department of Dermatology, Affiliated Hangzhou First People's Hospital, Zhejiang Chinese Medical University, Hangzhou, China.
  • Wu L; Department of, Dermatology, Affiliated Hangzhou First People's Hospital, Zhejiang University School of Medicine, Hangzhou, China.
Clin Exp Dermatol ; 47(2): 423-425, 2022 02.
Article em En | MEDLINE | ID: mdl-34482550
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Dermatite Atópica / Subunidade alfa de Receptor de Interleucina-4 / Uso Off-Label / Anticorpos Monoclonais Humanizados Limite: Child, preschool / Female / Humans / Male Idioma: En Ano de publicação: 2022 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Dermatite Atópica / Subunidade alfa de Receptor de Interleucina-4 / Uso Off-Label / Anticorpos Monoclonais Humanizados Limite: Child, preschool / Female / Humans / Male Idioma: En Ano de publicação: 2022 Tipo de documento: Article